Eyepoint Pharmaceuticals Inc Tangible Net Worth Ratio
Eyepoint Pharmaceuticals Inc tangible net worth ratio. Eyepoint Pharmaceuticals Inc (EYPT) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($200.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Eyepoint Pharmaceuticals Inc (EYPT) strategic asset index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Eyepoint Pharmaceuticals Inc (2000–2024)
Tangible net worth ratio of Eyepoint Pharmaceuticals Inc from 2000 to 2024. This chart shows how Eyepoint Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 24 annual periods from 2000 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $200.18 Million with intangible assets of $0.00 USD. See working capital position of Eyepoint Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Eyepoint Pharmaceuticals Inc Tangible Net Worth Ratio by Year (2000–2024)
Eyepoint Pharmaceuticals Inc tangible net worth ratio by year from 2000 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Eyepoint Pharmaceuticals Inc from 2000 to 2024, covering 24 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Eyepoint Pharmaceuticals Inc.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $336.50 Million | $0.00 | $418.46 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $266.32 Million | $0.00 | $355.18 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $96.37 Million | $0.00 | $180.36 Million | ▲ +12.3 pp |
| 2021 | 87.7% | $184.38 Million | $22.75 Million | $263.37 Million | ▲ +123.6 pp |
| 2020 | -36.0% | $18.54 Million | $25.21 Million | $91.72 Million | ▲ +196.2 pp |
| 2019 | -232.2% | $8.33 Million | $27.67 Million | $72.97 Million | ▼ -63.8 pp |
| 2018 | -168.3% | $11.69 Million | $31.36 Million | $71.67 Million | ▼ -265.6 pp |
| 2017 | 97.3% | $13.34 Million | $364.00K | $18.68 Million | ▲ +2.5 pp |
| 2016 | 94.7% | $20.88 Million | $1.10 Million | $31.62 Million | ▲ +3.0 pp |
| 2015 | 91.8% | $23.37 Million | $1.93 Million | $32.37 Million | ▲ +10.3 pp |
| 2014 | 81.5% | $14.92 Million | $2.77 Million | $22.67 Million | ▲ +26.0 pp |
| 2013 | 55.5% | $7.70 Million | $3.43 Million | $16.25 Million | ▼ -13.6 pp |
| 2012 | 69.0% | $13.64 Million | $4.23 Million | $20.60 Million | ▲ +26.6 pp |
| 2011 | 42.4% | $37.43 Million | $21.56 Million | $47.11 Million | ▲ +14.7 pp |
| 2010 | 27.7% | $33.04 Million | $23.88 Million | $43.01 Million | ▲ +50.1 pp |
| 2009 | -22.3% | $23.54 Million | $28.80 Million | $37.10 Million | ▲ +5.7 pp |
| 2008 | -28.0% | $21.79 Million | $27.90 Million | $39.23 Million | ▼ -68.2 pp |
| 2007 | 40.2% | $65.91 Million | $39.42 Million | $86.12 Million | ▲ +15.6 pp |
| 2006 | 24.6% | $66.20 Million | $49.90 Million | $97.60 Million | ▲ +5.7 pp |
| 2005 | 18.9% | $60.74 Million | $49.24 Million | $62.30 Million | ▲ +0.0 pp |
| 2004 | 18.9% | $60.74 Million | $49.24 Million | $62.30 Million | ▲ +65.0 pp |
| 2003 | -46.1% | $26.70 Million | $39.00 Million | $28.05 Million | ▼ -60.4 pp |
| 2002 | 14.3% | $4.23 Million | $3.63 Million | $4.82 Million | ▼ -28.7 pp |
| 2000 | 43.0% | $4.57 Million | $2.61 Million | $4.72 Million | — |